Trade-Ideas LLC identified Idera Pharmaceuticals Inc (NASDAQ:IDRA) as a “perilous reversal” candidate. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock opened at $5.33 in last session, and closed at $4.77, while the day range of IDRA stock is $4.54 – $5.54. The stock showed a positive weekly performance of 3.02%.
Prosensa Holding (NYSE:RNA) was downgraded by research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a report released on Monday, TheFlyOnTheWall.com reports. Prosensa Holding NV (NASDAQ:RNA) stock opened at $6.50, in last session and closed at $5.80, by losing -11.44 %. The 52 week range of the stock is $3.43 – $34.55. Company’s market capitalization is $208.23 billion.
Codexis, Inc. (NASDAQ:CDXS) has been assigned a patent (8,614,081) developed by four co-inventors for “nitrilase biocatalysts.” The co-inventors are Anke Krebber, Palo Alto, Calif., Emily Mundorff, Poughkeepsie, N.Y., Marissa Mock, Moorpark, Calif., and Spiros Kambourakis, Pasadena, Calif. Codexis, Inc. (NASDAQ:CDXS) stock decreased -6.58% and finished the last session at $1.42. The EPS of the stock remained -1.24. Company’s market capitalization is $54.11 billion.
BIND Therapeutics Inc (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins(TM), today announced that Greg Berk, M.D., Chief Medical Officer, will be leaving BIND to pursue another opportunity. Dr. Berk will serve as an advisor to BIND after his departure. BIND Therapeutics Inc (NASDAQ:BIND) stock opened the session at $14.00, and closed the session at $13.35. The 52 week range of the stock remained $8.36 – $15.89 and the day range was $12.62 -$14.06.